The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALLIED GOLD CORP | COM NEW | 01921D204 | 3,562,744 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| WARNER BROS DISCOVERY INC | COM SER A | 934423104 | 25,060,400 | 940,000 | SH | SOLE | 940,000 | 0 | 0 | ||
| AVANOS MED INC | COM | 05350V106 | 14,928,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| CINTAS CORP | COM | 172908105 | 2,003,542 | 11,780 | SH | SOLE | 11,780 | 0 | 0 | ||